For the Inventor, By the Inventor

Enter inventor name

Superior, CO, United States of America

Donghua Dai

USPTO Granted Patents = 6 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 14.3

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Boulder, CO (US) (2022 - 2023)
Superior, CO (US) (2022 - 2024)
Indianapolis, IN (US) (2024)

Company Filing History:

Array Biopharma Inc.

Mirati Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2022-2024

Loading Chart...

Loading Chart...

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11964989 - KRas G12D inhibitors (2024-04-23),

2. 11964988 - Fused heterocyclic compounds as RET kinase inhibitors (2024-04-23),

3. 11603374 - Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors (2023-03-14),

4. 11524963 - Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors (2022-12-13),

5. 11472802 - Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors (2022-10-18),

6. 11453683 - KRas G12D inhibitors (2022-09-27),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…